2020 U.S.-Booked Air Volume: $16.6 million
2020 Global T&E: $25 million
Primary Air Suppliers: Oneworld, SkyTeam, Star Alliance
Primary Hotel Suppliers: Hilton, Hyatt, Marriott
Primary Car Rental Supplier: Hertz
Primary U.S. Payment Supplier: American Express
Card Program: Individual Bill/Central Pay
Primary Global Expense Supplier: Concur
Primary Global Travel Risk Management Supplier: ISOS
Consolidated Global TMC: CWT
Biopharmaceutical company Amgen generated $25 billion in revenue in 2020. Its U.S.-booked air spend declined from $50.9 million in 2019 to $16.6 million in 2020. With business travel in nascent recovery mode following the Covid-19 pandemic, the company anticipates U.S.-booked air volume to be about $20 million in 2021. Returning to travel with well-being of staff is a high priority, as well as continued improvement through optimization of service, traveler experience and savings.
In 2020, Amgen’s travel department focused on communications, traveler education, stakeholder engagement, traveler well-being, supplier updates and recovery strategy, program impact and unused ticket management. Travel and expense policy changes include Covid-19 personal protective equipment and testing expense review. Amgen also is evaluating travel policy changes to support supplier saturation, refining travel approval and enhancing travel guidance and post-travel surveys.